Federal Health Grants

This funding opportunity supports the development of innovative molecular and genetic tools for neuroscientific research, enabling precise access to specific brain cell types across various vertebrate species, with a strong emphasis on collaboration, inclusivity, and resource sharing.

This grant provides funding to organizations already involved in breast and cervical cancer prevention to expand their services and address cardiovascular disease risk factors among underserved women.

The FY 2024 Children’s Mental Health Initiative (CMHI) funding opportunity, overseen by SAMHSA's Center for Mental Health Services, aims to support state and local governments, territories, and tribes in implementing and expanding comprehensive mental health services for children and youth up to age 21 who are at risk of or diagnosed with serious emotional disturbances (SED). The initiative provides grants to strengthen Systems of Care (SOC), focusing on sustainable infrastructure to support mental health outcomes and the well-being of children, youth, and their families. Applications for FY 2024 are due by February 14, 2024, with an estimated 23 awards. Grants provide up to $3,000,000 annually for state applicants and up to $1,000,000 for political sub-divisions, territories, and tribal organizations, with a four-year project period. The core objectives of the CMHI program include establishing or enhancing SOC frameworks that integrate cross-agency collaboration, policy development, and evidence-based interventions for children and families. Funded projects must conduct a needs assessment within the first four months, focusing on gaps in services and identifying disparities based on race, ethnicity, and other social determinants. Required services include 24-hour mental health crisis support, intensive case management, therapeutic foster care, and transition services to support youth moving to adult systems. Recipients are also expected to provide culturally appropriate mental health services for underserved populations, including racial minorities, LGBTQ+ youth, and those in rural areas. Eligible applicants must register in eRA Commons, Grants.gov, and SAM.gov. A cost match is required, with recipients matching $1 for every $3 of federal funds in the first three years, and $1 for each $1 in the fourth year. Applications should include a project narrative limited to 10 pages, detailed budget documentation, and a Disparity Impact Statement (DIS) to address behavioral health disparities. Key personnel must include a Project Director and a Lead Family Coordinator, each with a minimum 0.75 FTE. Evaluation criteria include the program’s feasibility, organizational capacity, sustainability plan, and commitment to evidence-based practices. Proposals will be scored on their effectiveness in meeting SAMHSA’s program goals, including improvements in the SOC, reduction in behavioral health disparities, and long-term sustainability. Funded projects must report progress annually and submit performance data through SAMHSA’s SPARS system, tracking program impact on mental health outcomes and service reach within the target population.

This funding opportunity supports doctoral students from underrepresented backgrounds in mental health research to complete their dissertation projects and advance their careers in the field.

This funding opportunity supports research projects that aim to improve access to and effectiveness of treatment for Alcohol Use Disorder, particularly for underserved populations, by addressing barriers and enhancing care delivery.

This funding opportunity provides financial support for a diverse range of organizations to collaborate on improving the reliability and standardization of biomarker research in Type 1 Diabetes, ultimately enhancing clinical management and patient outcomes.

This program provides funding to local organizations in Arkansas to help reduce poverty and support low-income individuals through services like employment, education, housing, nutrition, and health.

This is a non-competitive funding opportunity intended to fund a single award. The National Institute of Neurological Disorders and Stroke is announcing its intent to issue a single source cooperative agreementto the Hennepin Healthcare Research Institute to submit a renewal application to complete the phase II Hyperbaric Oxygen Brain Injury Treatment (HOBIT) clinical trial.

This grant provides funding to a variety of organizations to implement effective HIV/AIDS prevention, care, and treatment services in the Kinshasa and Haut Katanga regions of the Democratic Republic of Congo.

This funding opportunity is designed to improve access to quality health services for women and children in five provinces of Afghanistan, focusing on critical health issues such as maternal and newborn health, family planning, and nutrition.

This funding opportunity provides financial support to veterinary scientists who have received a specific career development award, helping them transition to independent research by enabling small-scale projects that build on their existing work.

This funding opportunity supports researchers who have received a specific career development award to conduct small-scale projects that will help them become independent investigators.

This program provides funding to healthcare organizations to improve access to and quality of care for individuals with sickle cell disease through coordinated regional networks.

This program provides funding to established rural health networks to improve healthcare access, quality, and sustainability in rural communities across the U.S.

The NIAID Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional), designated as PAR-22-241, is a funding opportunity issued by the NIH's National Institute of Allergy and Infectious Diseases (NIAID). The program targets New Investigators (NI) and At-Risk Investigators from underrepresented backgrounds in the biomedical, clinical, behavioral, and social sciences. New Investigators are those who have not previously secured substantial independent NIH funding, while At-Risk Investigators are those with previous funding but face a lack of funding in the following fiscal year unless a new grant is awarded. This initiative aligns with the goals of the 21st Century Cures Act to encourage new researchers, foster early independence, and support a more diverse scientific workforce. This funding announcement supports research relevant to the NIAID mission, including the study and treatment of infectious, immunologic, and allergic diseases. Research areas of focus include microbiology, immunology, infectious diseases, AIDS, transplantation, and emerging diseases. Although clinical trials are optional, applicants proposing NIH-defined clinical trials must consult with NIAID before submission. The funding opportunity is open to projects that advance diversity in the R01 investigator pool and those promoting representation from underrepresented groups in line with NIH’s interest in enhancing diversity across all health-related fields. To apply, investigators must be affiliated with U.S.-based higher education institutions or eligible nonprofits and for-profit organizations. This opportunity is also open to minority-serving institutions, such as Hispanic-serving Institutions, HBCUs, and Tribally Controlled Colleges and Universities. Non-domestic (non-U.S.) entities are not eligible, although foreign components of U.S. organizations are permitted. An essential part of the application process is an Eligibility Certification Letter from the applicant institution verifying the applicant’s eligibility and alignment with the program’s diversity objectives. Applications missing this letter will be considered incomplete. Funding levels are based on the project’s actual needs and are not capped, with a project duration of up to five years. NIAID also expects applicants to allocate funding in their budgets for mandatory attendance at a workshop designed to foster networking, collaboration, and professional growth among awardees, to be held every three years starting in 2025. Additional support for necessary accommodations for researchers with disabilities may also be included in the budget. The application process requires thorough adherence to NIH’s submission guidelines, which include registrations with SAM, Grants.gov, eRA Commons, and the acquisition of a UEI. Applications are accepted electronically through the NIH ASSIST system, Grants.gov Workspace, or a system-to-system solution. The next deadline cycle follows NIH’s standard due dates, with submissions due at 5:00 PM local time. Applicants are advised to submit early to address potential errors before the due date. Applications will be evaluated on scientific merit and alignment with program priorities, using criteria focused on the significance of the research, investigator qualifications, project innovation, approach, and institutional environment. Specific review criteria for clinical trials include the adequacy of study design, data management, and statistical analysis plans. Following peer review, recommended applications will receive secondary review by the NIAID advisory council. Final award decisions consider both scientific merit and relevance to NIAID’s mission and diversity goals.

This funding opportunity supports researchers in developing innovative theories and methods to better understand the complex genetic and non-genetic factors influencing human traits and health, with a focus on interdisciplinary approaches and diverse perspectives.

This funding opportunity supports large-scale health services research projects that aim to improve healthcare quality, safety, and delivery by partnering with various stakeholders, including patients and policymakers.

The purpose of this program is to address the public health crisis caused by escalating opioid misuse, opioid use disorder (OUD), and opioid-related overdose across the nation. States and territories are expected to use the resources to: (1) increase access to U.S. Food and Drug Administration (FDA)-approved medications for the treatment of opioid use disorder (MOUD); (2) support the continuum of prevention, harm reduction, treatment, and recovery support services for OUD and other concurrent substance use disorders; and (3) support the continuum of care for stimulant misuse and use disorders, including those involving cocaine and methamphetamine.

Amendment 1 (June 25, 2024): The purpose of this Amendment 1 is to: 1) make administrative updates to Section 1.1, 1.2, 2.1.2, 3.1, 3.2 and 5.2.6; 2) replace Section 2.1.1 with new language pertaining to Federally Funded Research and Development Centers (FFRDCs) and Government Entities. Additionally, Section 4.2, Evaluation Criteria #2 is updated to remove the reference to Government Entities (removal is not highlighted in yellow); 3) change references from Abstract to Solution Summaries (intent behind the document is unchanged); 4) update proposal submission instructions in Section 3.2; and 5) update Section 5.1 to remove the Stage 2 Notification Letter. All changes are highlighted in yellow.Also, please note that the title of this opportunity has bee revised to eliminate confusion. The opportunity should have been titled, "Master Announcement Instruction (MAI)" instead of "ARPA-H BDF Tool Box".The Master Announcement Instructions (MAI) is a new ARPA-H announcement that aims to create standard tiered proposal submission requirements, so the amount of work required to write a proposal is commensurate with the size of the proposed effort. It also aims to reduce the up-front work required to submit cost information to reduce the barrier to entry for non-traditional performers. Module announcements that link to this MAI will provide more specific instructions about how the proposal requirements vary across tiers of effort.All responsible sources capable of satisfying the Governments needs may submit a proposal to a Module Announcement. Specifically, universities, non-profit organizations, small businesses and other than small businesses are eligible and encouraged to propose to Module Announcements.NOTE: Proposals shall NOT be submitted against the MAI. Proposals shall only be submitted against a Module Announcement.

This funding opportunity provides support for mid-career and senior researchers to gain new skills and knowledge in dental, oral, and craniofacial research by collaborating with experts in different scientific fields.